Summary:
Regenetech uses a NASA based technology, originally discovered in space shuttle experiments, for a proprietary method of growing stem cells three-dimensionally (3D) in a simulated weightless environment. The Company's technology is utilized after harvesting adult stem cells from patient's peripheral blood to filter and proliferate (expand) therapeutic quantities before re-introducing them back into the original patient.
Visit Regenetech, Inc..

Description (Web site quote):
This technology and process allows the cells to be injected into the blood stream and potentially restore the malady. This process could eliminate the need for bone marrow transplants. If successful, the processes may result in a treatment for the reduction of Chemotherapy side effects as well as treatments for other significant illness' including, heart attacks, diabetes, cirrhosis, and the repair of damaged tissue throughout the body.

The Company's preliminary research indicates that adult stem cells can be grown and harvested from a filtered extraction of the patient's own blood. This minimally invasive procedure reintroduces the patient's own stem cells to provide the repair and regeneration of the body tissue damaged by disease or trauma.

Regenetech has the exclusive rights to thirteen (13) patents originally issued to NASA. The Company has added to the original technology licensed from NASA through its Technology Transfer Program by applying for over 30 patent applications of its own with an additional one-hundred (100) patents in development.
Visit Regenetech, Inc..